NeurogesX, Inc. to Hold Conference Call to Discuss Second Quarter 2012 Results
SAN MATEO, Calif., July 27, 2012 (GLOBE NEWSWIRE) -- NeurogesX, Inc. (OTCQB:NGSX) (OTCBB:NGSX), a specialty pharmaceutical company focused on developing and commercializing a portfolio of novel non-opioid, pain management therapies, today announced it will hold a conference call on Friday, August 3, 2012, at 8:30 a.m. ET (5:30 a.m. PT) to report results for its second quarter ended June 30, 2012.